Related Experiment Video
Updated: Feb 16, 2026

08:51
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
9.9K
A structural MRI study of cholinergic pathways and cognition in multiple sclerosis
Yukio Kimura1, Noriko Sato1, Miho Ota2
1Department of Radiology, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.
Eneurologicalsci
|December 21, 2017
Summary
White matter hyperintensities (WMH) in multiple sclerosis (MS) correlate with cognitive decline. The Cholinergic Pathways Hyperintensities Scale (CHIPS) showed less sensitivity to WMH volume compared to direct volume measurements in assessing cognitive function.
Area of Science:
- Neuroimaging
- Neurology
- Cognitive Science
Background:
- White matter hyperintensities (WMH) in cholinergic pathways are linked to cognitive deficits in Alzheimer's disease.
- Investigating WMH and cholinergic pathway volume reduction in multiple sclerosis (MS) is crucial for understanding cognitive impairment.
Purpose of the Study:
- To evaluate the relationship between cholinergic pathway volume reduction and cognitive function in MS patients.
- To compare the effectiveness of the Cholinergic Pathways Hyperintensities Scale (CHIPS) with direct WMH volume measurements.
Main Methods:
- Thirty-two MS patients underwent MRI for WMH assessment (CHIPS, direct volume) and cognitive tests (MMSE, MoCA-J).
- Regional brain volumes, including cortical and subcortical structures, were measured using FreeSurfer.
- Correlations between CHIPS scores, WMH volumes, and cognitive scores were analyzed.
Main Results:
- CHIPS scores and WMH volumes were highly correlated (r=0.87).
- Both CHIPS scores and WMH volumes negatively correlated with MMSE and MoCA-J scores.
- Cognitive scores positively correlated with corpus callosum volume, as measured by FreeSurfer.
Conclusions:
- Direct WMH volume measurements appear more sensitive than CHIPS in reflecting cognitive function in MS.
- The CHIPS method may be less effective for evaluating cognitive impact in MS patients.
- Further research is needed to refine WMH assessment in MS-related cognitive decline.

